Cost effectiveness of treating cancer in Africa
On 21 November 2013 an International Workshop on Cost Effectiveness of Treating Cancer in Africa.
Date: 21 November 2013
Venue: Mkhomazi 1 room at Hilton Durban Hotel
Time: 08h30 – 16h00
This workshop is open to all AORTIC delegates. It is jointly organized by African colleagues from Senegal, Zimbabwe, Rwanda and South Africa and is intended to be a first step in creating a network of institutions that will collaborate on cancer research and economic evaluations in Africa.
The economic impact of cancer interventions will be discussed and the collaborators will come up with a strategy on research collaboration and capacity building.
Registration is free for AORTIC delegates! Please send short abstracts/contributions for possible inclusion.
Contact Person: Prof DC Stefan
Email: cs@sun.ac.za
Thursday 21 November 2013
| 08:30-09:00 | Registration |
| 09:00-09:10 | Welcome DC Stefan (Chair: Organizing Committee) & Dr F Ntaganda (co-chair) |
| 09:10-09:20 | Address JM Dangou -WHO Africa |
| 09:20-09:30 | Address by President of AORTIC A Elzawawy |
Chairs: JM Dangou, A Elzawawy
| 09:30-09:45 | Global cancer burden with emphasis on Africa Freddie Bray IARC, Lyon |
| 09:45-09:55 | Childhood cancer in Africa – today and tomorrow DC Stefan, South Africa |
| 09:55-10:20 | How to calculate the cost and cost effectiveness of cancer treatment
in Africa S Horton, Canada |
| 10:20-10:30 | Cost effectiveness of cancer therapy: Emerging evidence of relevance
in low- and middle-income countries CK Williams, Canada |
Cost of cancer treatment in:
| 10:30-10:40 | Rwanda F Ntaganda, Rwanda |
| 10:40-10:50 | Senegal (GFAOP) C Moreira, Senegal |
| 10:50-11:00 | Uganda: Challenges of treatment of BL C Casper, USA |
| 11:00-11:30 | Tea / Coffee |
Chairs: S Horton, F Ntaganda
Cost of cancer care:
| 11:30-11:40 | Zimbabwe I Chitsike, Zimbabwe |
| 11:40-11:50 | Malawi S Gupta, Canada |
| 11:50-12:00 | South Africa A Van Zyl, South Africa |
| 12:00-12:10 | Template for cost analysis and cost effectiveness: which variables to use? C Kay, South Africa |
| 12:10-12:30 | Parallel discussion groups: Coordinated by Prof A
Elzawawy Eastern Africa, Northern Africa, Southern Africa, Western Africa |
| 12:30-13:00 | Feedback session from discussion groups (5 minutes per group) |
| 13:00-14:00 | Lunch |
Chairs: I Chitsike, C Moreira
| 14:00-14:30 | Cost and availability of commonly used chemotherapeutic agents- interaction with pharmaceutical companies (GSK- Eva Gubern Anfruns , Roche, Novartis- Franck Mournier) |
| 14:30-14:40 | Correlation of survival with cost (Hodgkin lymphoma, nephroblastoma,
Kaposi and Burkitt lymphoma) - South African calculations – Dr G De Bruin, South Africa |
| 14:40-14:50 | The African childhood tumour: nephroblastoma survival globally Prof N Graf, Germany |
| 14:50-15:00 | Childhood cancer awareness – CHOC: The role of parents in South Africa
and Africa Mr F Peenz, South Africa |
| 15:00-15:15 | Implementation of Cancer Care Services in Rwanda K Lenny, Rwanda |
| 15:15-15:45 | Establishing a working group to study the “Cost of cancer care and cost
effectiveness in Africa” All participants |
| 15:45-16:00 | Closing remarks |
| 16:00-16:30 | Tea / Coffee |
